Revenue for the Nine Months Ended September 30, 2025 Increased 14%
Income from Operations for the Nine Months Ended September 30, 2025 Increased 58%
Net Income for the Nine Months Ended September 30, 2025 Increased 166%
Record quarterly revenue of $10.1 million in Q3; a more than 6-fold increase YoY and 60% growth QoQ
With a pro-forma cash balance of $840.4 million, we believe Ondas has one of the strongest balance sheets in the industry
Ondas is effectively deploying capital through acquisitions and investments highlighted by Sentrycs, Apeiro Motion, 4M Defense, and Rift Dynamics
2025 revenue target increased to at least $36 million; establishing preliminary revenue target of at least $110 million for 2026
Conference Call Scheduled for Today at 8:30 a.m. ET
Read MoreTHE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM
Read MoreNamed as Representative Vendor in Gartner Market Guide for Workplace Experience Applications 2025
Strategic collaboration with Noro announced to transform hybrid work with Agentic AI and immersive presence technology
Major enterprise client expansion including iconic 30 Rock campus launch and platform migration initiatives
Read More
As Congress and the courts reaffirm federal supremacy in cannabis-hemp regulation, MMJ International Holdings stands with a DEA licensed lab, two accepted FDA Investigational new drug applications, and a completed THC-CBD soft gelatin medicine-proving that true compliance, not state loopholes, defines the future of cannabis medicine.
Read More
Experience Luxury Without Limits at Esprit at Avenir, where country club living, a full-service restaurant, and resort-style amenities redefine 55+ living in Palm Beach Gardens
Read MoreUnlike Typical Tech Announcements, Whitepaper Documents Already Built and Validated Production System; Five Patent Pending Innovations Ahead of Q1 2026 Launch
Read More
This press release corrects and replaces the previous release distributed November 11, 2025 at 3:10 pm ET.
The previous release contained an incorrect name in the quoted in the Central Pennsylvania: A Legacy of Trust section.
The full corrected release follows.
Read MoreShore Fire Clients Alison Krauss & Union Station, Anoushka Shankar, Arturo O'Farrill & The Afro Latin Jazz Orchestra, Bon Iver, Margo Price, PJ Morton, Samara Joy, Tasha Cobbs Leonard, Tobias Jesso Jr. and 42West Client Andrew Watt All Receive Multiple Nominations
Additional Nods Include Shore Fire Clients Bilal, Bruce Springsteen, Deborah Silver & The Count Basie Orchestra, Grace Potter, Jacob Collier, Joni Mitchell (Rhino Entertainment), Rhiannon Giddens, Samantha Fish, TajMo (Taj Mahal & Keb' Mo'), Terri Lyne Carrington and Trombone Shorty
Read More
New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent cell penetration and iron-modulating activity - key to its broader epigenetic mechanism of action.
Read MoreConsolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and manufacturers
Integration of technology and physical infrastructure positions Wellgistics with the "Pharmacy IT Railroad" to execute on PharmacyChain™ smart contracts for optimized healthcare delivery in the $634 billion United States prescription drug market
With a staggering 1405.46% revenue surge since February 2024, CBDL continues its explosive expansion as Smoking Scholars places another major order in New York's $7.2 billion cannabis market.
Read MoreThird Quarter Highlights
Per Class B share(3): $1.21 adjusted basic earnings up 11.0%; $1.21 basic earnings up 12.0%
Sales increased 6.3% on 3.7% organic growth, 0.1% acquisition growth and 2.5% positive currency translation
Operating income(1) improved 11.4%, with a 16.4% operating margin(1) up 80 bps
Returned $155.8 million to shareholders: $55.8 million in dividends and repurchased 1.3 million Class B shares for $100.0 million
Nine-Month Highlights
Per Class B share(3): $3.61 adjusted basic earnings up 9.4%; $3.60 basic earnings down 3.2%; 2024 included $0.44 revaluation gain in basic earnings
Sales increased 6.5% on 3.1% organic growth, 0.8% acquisition growth and 2.6% positive currency translation
Operating income(1) improved 9.9%, with a 16.6% operating margin(1) up 50 bps
Returned $467.9 million to shareholders: $167.9 million in dividends and repurchased 3.9 million Class B shares for $300.0 million